| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/16/2009 | WO2009088553A1 Dry powder drug delivery formulations, methods of use, and devices therefore |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009050183A3 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 07/16/2009 | WO2009046860A3 Use of dago as a therapeutic agent |
| 07/16/2009 | WO2009046859A3 Use of af12198 and dago as therapeutic agents |
| 07/16/2009 | WO2009040035A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2009039990A3 Use of icam peptide as a therapeutic agent |
| 07/16/2009 | WO2009039974A3 Use of peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/16/2009 | WO2009033817A3 Use of the combination of the hcv-1 e2 protein (484-499) and the human pancreatic polypeptide as a therapeutic agent |
| 07/16/2009 | WO2009033766A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2008131859A3 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia |
| 07/16/2009 | WO2008131858A3 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia |
| 07/16/2009 | US20090182033 Cyclic Amine Derivatives and Their Uses |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090182010 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181961 Novel medicaments for the treatment of respiratory diseases |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181935 Compositions comprising an antimuscarinic and a long-acting beta-agonist |
| 07/16/2009 | US20090181934 Organic Compounds |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181096 Method Of Targeting Sustained Release Formulations Of Therapeutic Agents To Treat Lung Diseases |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181055 Gallibacterium anatis isolate BIV-07990 deposited with ATCC under accession number ATCC No.PTA-3669; beta( beta )-haemolysis-positive, Gram-negative, oxidase-positive, catalase-positive, urease-negative, nitrate-positive and indole-negative; for treatment of respiratory diseases in poultry |
| 07/16/2009 | US20090180969 Pharmaceutical formulation comprising an anticholinergic drug |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711292A1 Inhalation drug products, systems and uses |
| 07/15/2009 | EP2078525A2 Treatment of tuberculosis using immunomodulator compounds |
| 07/15/2009 | EP2078027A1 Cathepsin proteases inhibitors |
| 07/15/2009 | EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 07/15/2009 | EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 07/15/2009 | EP1773361B1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512841C Medication for treating bronchitis |
| 07/15/2009 | CN100512833C Medication for treating cough |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560479 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | CA2503718C Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/09/2009 | WO2009086470A2 Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
| 07/09/2009 | WO2009086055A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | WO2009085651A1 Metal carbonate particles for use in medicine and methods of making thereof |
| 07/09/2009 | WO2009084970A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009083738A2 Rna delivery vehicles |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2009023509A3 Therapeutic combinations useful in treating cftr related diseases |
| 07/09/2009 | WO2008147864A3 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176856 Muscarinic receptor antagonists |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176848 Fortifier |
| 07/09/2009 | US20090176833 biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; pulmonary disorders |
| 07/09/2009 | US20090176818 Antitussive Agent |
| 07/09/2009 | US20090176815 Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor Activity |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176767 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma |
| 07/09/2009 | US20090176751 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/09/2009 | US20090176741 Modulation of the immune system by inositol phospholipids |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090175971 Method of using composition comprising pomegranate extracts against the common cold |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | DE10319109B4 Verfahren zur Herstellung eines Extraktes von Cynanchum Atratum oder Cynanchum Versicolor und dessen Verwendung als Antitussivum A process for the preparation of an extract of Cynanchum atratum or Cynanchum Versicolor and its use as an antitussive |
| 07/09/2009 | CA2710743A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | CA2710349A1 Aerosolized nitrite and nitric oxide -donating compounds and uses thereof |
| 07/09/2009 | CA2710271A1 Enhancing photostabilization of oxymetazoline |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077271A1 Macrolide derivative |